- Home
- CAPT vs RPTX Comparison
CAPT vs RPTX Comparison
Compare CAPT & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- RPTX
- Stock Information
- Founded
- CAPT 2005
- RPTX 2016
- Country
- CAPT South Korea
- RPTX Canada
- Employees
- CAPT N/A
- RPTX N/A
- Industry
- CAPT Blank Checks
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- RPTX Health Care
- Exchange
- CAPT Nasdaq
- RPTX Nasdaq
- Market Cap
- CAPT 54.4M
- RPTX 64.8M
- IPO Year
- CAPT N/A
- RPTX 2020
- Fundamental
- Price
- CAPT $1.25
- RPTX $1.50
- Analyst Decision
- CAPT
- RPTX Strong Buy
- Analyst Count
- CAPT 0
- RPTX 3
- Target Price
- CAPT N/A
- RPTX $4.50
- AVG Volume (30 Days)
- CAPT 478.8K
- RPTX 724.4K
- Earning Date
- CAPT 01-01-0001
- RPTX 08-12-2025
- Dividend Yield
- CAPT N/A
- RPTX N/A
- EPS Growth
- CAPT N/A
- RPTX N/A
- EPS
- CAPT N/A
- RPTX N/A
- Revenue
- CAPT $17,389,944.00
- RPTX $1,073,000.00
- Revenue This Year
- CAPT N/A
- RPTX N/A
- Revenue Next Year
- CAPT N/A
- RPTX N/A
- P/E Ratio
- CAPT N/A
- RPTX N/A
- Revenue Growth
- CAPT 84.70
- RPTX N/A
- 52 Week Low
- CAPT $0.37
- RPTX $0.89
- 52 Week High
- CAPT $2.60
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- CAPT 43.15
- RPTX 50.25
- Support Level
- CAPT $1.45
- RPTX $1.50
- Resistance Level
- CAPT $1.57
- RPTX $1.62
- Average True Range (ATR)
- CAPT 0.13
- RPTX 0.07
- MACD
- CAPT -0.05
- RPTX -0.01
- Stochastic Oscillator
- CAPT 2.16
- RPTX 41.94
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.